Impact of the New Pharmacovigilance Legislation - Key Industry and Regulatory Perspective
19th September 2012
03:32 EDT 23rd May 2013 | BioPortfolio
Impact of the New Pharmacovigilance Legislation - Key Industry and Regulatory Perspective
Benefits of attending this meeting include:
- Discover the Regulator's expectations of the new Legislation
- Understand the new quality management System requirements
- Clarify the implications and responsibilities for the MAH and QPPV
- Gain an understnading of the new expectations for signal management/detection
- Discuss provision of safety signal and benefit-risk information.
Expected Number of Attendees
0-50
View Conference Website: Impact of the New Pharmacovigilance Legislation - Key Industry and Regulatory Perspective
Contact
Name: Leigh White
Email: info@management-forum.co.uk
Tel.: 44 1483 730071
URL: Website
Price of Attendance
£575 + VAT
Brochure
Location
The Rembrandt Hotel
11 Thurloe Place
London
United Kingdom
SW7 2RS
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
